Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis
Authors:
- 6 January 2009
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 117 (2) , 391-399
Abstract
Several polymorphisms in the vitamin D receptor (VDR) gene have been reported to influence breast cancer risk. However, the published findings have been conflicting. We conducted a meta-analysis of 21 case–control studies with Fok1 (eight studies with 5,284 cases and 7,500 controls), Bsm1 (14 studies with 5,498 cases and 7,943 controls), Apa1 (four studies with 1,138 cases and 7,943 controls), Taq1 (10 studies with 4,459 cases and 5,485 controls) polymorphisms. The results showed Fok1 polymorphism was associated with an overall significantly increased risk of breast cancer (ff vs. FF: OR = 1.15, 95% CI = 1.03–1.28; the recessive model ff vs. Ff + FF: OR = 1.14, 95% CI = 1.03–1.26). In subgroup analysis, a significant association was evident between Fok1 polymorphism and breast cancer in European population (ff vs. FF: OR = 1.16, 95% CI = 1.04–1.30; the recessive model ff vs. Ff + FF: OR = 1.15, 95% CI = 1.04–1.28). There was no between-study heterogeneity in any of these analyses. No significant associations were observed between the Bsm1, Apa1 and Taq1 variants and breast cancer risk. So, the current meta-analysis shows that Fok1 may be a susceptibility biomarker for breast cancer especially in European population.Keywords
This publication has 34 references indexed in Scilit:
- Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer riskBreast Cancer Research, 2008
- Sun Exposure, Vitamin D Receptor Gene Polymorphisms, and Breast Cancer Risk in a Multiethnic PopulationAmerican Journal of Epidemiology, 2007
- Promoter and 3′-Untranslated-Region Haplotypes in the Vitamin D Receptor Gene Predispose to Osteoporotic Fracture: The Rotterdam StudyThe American Journal of Human Genetics, 2005
- Associations Between Polymorphisms in the Vitamin D Receptor and Breast Cancer RiskCancer Epidemiology, Biomarkers & Prevention, 2005
- Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- Autocrine Metabolism of Vitamin D in Normal and Malignant Breast TissueClinical Cancer Research, 2005
- Vitamin D Receptor Gene Polymorphisms and Breast Cancer RiskClinical Cancer Research, 2004
- Intake of Dairy Products, Calcium, and Vitamin D and Risk of Breast CancerJNCI: Journal of the National Cancer Institute, 2002
- Association of a vitamin D receptor polymorphism with sporadic breast cancer developmentInternational Journal of Cancer, 1999
- Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcriptsProceedings of the National Academy of Sciences, 1998